Published in Infect Immun on April 01, 1995
Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med (2004) 3.02
Spirochaetal lipoproteins and pathogenesis. Microbiology (2000) 2.30
Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev (2004) 1.87
Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect Immun (1997) 1.79
Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Infect Immun (1999) 1.74
Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol (2008) 1.51
Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci U S A (2003) 1.50
A surface-exposed region of a novel outer membrane protein (P66) of Borrelia spp. is variable in size and sequence. J Bacteriol (1998) 1.30
Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato. Infect Immun (1998) 1.21
Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector. Infect Immun (2008) 1.21
Entry of Borrelia burgdorferi into macrophages is end-on and leads to degradation in lysosomes. Infect Immun (1996) 1.17
The role of Borrelia burgdorferi outer surface proteins. FEMS Immunol Med Microbiol (2012) 1.16
Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes. Infect Immun (2000) 1.14
Borrelia burgdorferi RevA antigen is a surface-exposed outer membrane protein whose expression is regulated in response to environmental temperature and pH. Infect Immun (2001) 1.13
P13, an integral membrane protein of Borrelia burgdorferi, is C-terminally processed and contains surface-exposed domains. Infect Immun (2001) 1.13
Molecular cloning and characterization of nlpH, encoding a novel, surface-exposed, polymorphic, plasmid-encoded 33-kilodalton lipoprotein of Borrelia afzelii. J Bacteriol (1996) 1.12
Pleiotropic effects of inactivating a carboxyl-terminal protease, CtpA, in Borrelia burgdorferi. J Bacteriol (2004) 1.08
Surface protein variation by expression site switching in the relapsing fever agent Borrelia hermsii. Infect Immun (2000) 1.06
Elimination of channel-forming activity by insertional inactivation of the p13 gene in Borrelia burgdorferi. J Bacteriol (2002) 1.06
In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun (2001) 1.05
Characterization of multiprotein complexes of the Borrelia burgdorferi outer membrane vesicles. J Proteome Res (2011) 1.04
The nucleotide sequence of a linear plasmid of Borrelia burgdorferi reveals similarities to those of circular plasmids of other prokaryotes. J Bacteriol (1996) 1.03
Quantitative analysis of Borrelia burgdorferi gene expression in naturally (tick) infected mouse strains. Med Microbiol Immunol (2005) 0.98
Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in alphabeta T-cell receptor transgenic mice. Infect Immun (1997) 0.95
Abrogation of ospAB constitutively activates the Rrp2-RpoN-RpoS pathway (sigmaN-sigmaS cascade) in Borrelia burgdorferi. Mol Microbiol (2008) 0.93
Function and evolution of plasmid-borne genes for pyrimidine biosynthesis in Borrelia spp. J Bacteriol (2006) 0.92
Surface localization determinants of Borrelia OspC/Vsp family lipoproteins. J Bacteriol (2011) 0.91
Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A. Infect Immun (2000) 0.89
Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infect Immun (2006) 0.88
Alp, an arthropod-associated outer membrane protein of Borrelia species that cause relapsing fever. Infect Immun (2012) 0.87
The BBA01 protein, a member of paralog family 48 from Borrelia burgdorferi, is potentially interchangeable with the channel-forming protein P13. J Bacteriol (2006) 0.86
Extracellular secretion of the Borrelia burgdorferi Oms28 porin and Bgp, a glycosaminoglycan binding protein. Infect Immun (2004) 0.86
Specificity and role of the Borrelia burgdorferi CtpA protease in outer membrane protein processing. J Bacteriol (2011) 0.86
Probing the Borrelia burgdorferi surface lipoprotein secretion pathway using a conditionally folding protein domain. J Bacteriol (2011) 0.81
Determination of Borrelia surface lipoprotein anchor topology by surface proteolysis. J Bacteriol (2011) 0.81
Characterization of Borrelia burgdorferi aggregates. Vector Borne Zoonotic Dis (2009) 0.81
Two regulatory elements required for enhancing ospA expression in Borrelia burgdorferi grown in vitro but repressing its expression during mammalian infection. Microbiology (2010) 0.80
Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex. PLoS Pathog (2016) 0.80
A short-term Borrelia burgdorferi infection model identifies tissue tropisms and bloodstream survival conferred by adhesion proteins. Infect Immun (2015) 0.79
Borrelia burgdorferi elongation factor EF-Tu is an immunogenic protein during Lyme borreliosis. Emerg Microbes Infect (2015) 0.78
Consensus computational network analysis for identifying candidate outer membrane proteins from Borrelia spirochetes. BMC Microbiol (2016) 0.77
Interaction of variable bacterial outer membrane lipoproteins with brain endothelium. PLoS One (2010) 0.76
The Cross-Talk between Spirochetal Lipoproteins and Immunity. Front Immunol (2014) 0.76
Spirochetal Lipoproteins and Immune Evasion. Front Immunol (2017) 0.75
Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun (1983) 9.60
Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol (1992) 7.82
A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun (1986) 6.80
Variation in a major surface protein of Lyme disease spirochetes. Infect Immun (1984) 6.68
Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol (1989) 6.51
Biology of Borrelia species. Microbiol Rev (1986) 6.03
Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science (1987) 5.80
Variable major proteins of Borrellia hermsii. J Exp Med (1982) 5.62
Anatomy and chemistry of spirochetes. Microbiol Rev (1978) 5.27
The biological and social phenomenon of Lyme disease. Science (1993) 4.76
Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol (1991) 4.59
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect Immun (1992) 4.42
Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun (1993) 4.16
Genomic fingerprinting by arbitrarily primed polymerase chain reaction resolves Borrelia burgdorferi into three distinct phyletic groups. Int J Syst Bacteriol (1992) 4.16
Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect Immun (1990) 4.10
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell (1985) 3.78
Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis (1993) 3.73
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun (1994) 3.59
The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50
A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science (1985) 3.42
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med (1992) 3.30
Outer membrane ultrastructure explains the limited antigenicity of virulent Treponema pallidum. Proc Natl Acad Sci U S A (1989) 3.17
Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect Immun (1989) 2.76
Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins. Infect Immun (1992) 2.67
Biochemical and immunological characterization of the surface proteins of Borrelia burgdorferi. Infect Immun (1989) 2.56
Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect Immun (1989) 2.45
Linear- and circular-plasmid copy numbers in Borrelia burgdorferi. J Bacteriol (1992) 2.45
Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals. J Clin Microbiol (1991) 2.32
In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis (1993) 2.31
Population genetic analysis of Borrelia burgdorferi isolates by multilocus enzyme electrophoresis. Infect Immun (1992) 2.28
Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB. Infect Immun (1992) 2.19
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun (1993) 2.18
Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1987) 2.15
Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway. Infect Immun (1988) 1.97
Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun (1993) 1.95
A flagella-less mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization. J Clin Invest (1991) 1.95
Biological activity of Borrelia burgdorferi antigens. Ann N Y Acad Sci (1988) 1.90
Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A (1990) 1.87
Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect Dis (1993) 1.84
Linear DNA of Borrelia species and antigenic variation. Trends Microbiol (1993) 1.79
An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo. Infect Immun (1993) 1.79
Immunochemical analysis of Lyme disease spirochetes. Yale J Biol Med (1985) 1.74
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med (1994) 1.73
A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Infect Immun (1993) 1.43
Characterization of Borrelia burgdorferi invasion of cultured endothelial cells. Microb Pathog (1991) 1.41
Purification and immunological characterization of a major low-molecular-weight lipoprotein from Borrelia burgdorferi. Infect Immun (1992) 1.27
A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun (1994) 1.24
Differences of two Borrelia burgdorferi strains in complement activation and serum resistance. Immunobiology (1992) 1.11
A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology (1994) 1.02
Immunological characterization of a low molecular mass polypeptidic antigen of Borrelia burgdorferi. FEMS Microbiol Immunol (1991) 0.99
Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun (1983) 9.60
Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J Infect Dis (1985) 7.69
A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun (1986) 6.80
Variation in a major surface protein of Lyme disease spirochetes. Infect Immun (1984) 6.68
Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol (1989) 6.51
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
Biology of Borrelia species. Microbiol Rev (1986) 6.03
Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science (1987) 5.80
Variable major proteins of Borrellia hermsii. J Exp Med (1982) 5.62
Natural Distribution of the Ixodes dammini spirochete. Science (1983) 5.24
Antigenic variability of Borrelia burgdorferi. Ann N Y Acad Sci (1988) 5.02
Spirochetes in Ixodes dammini and mammals from Connecticut. Am J Trop Med Hyg (1983) 4.86
Mechanochemical coupling in actomyosin energy transduction studied by in vitro movement assay. J Mol Biol (1990) 4.78
Characteristics and purification of PRR1, an RNA phage specific for the broad host range Pseudomonas R1822 drug resistance plasmid. J Virol (1973) 4.51
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect Immun (1992) 4.42
Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature (1985) 4.41
Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent. Proc Natl Acad Sci U S A (1989) 4.38
Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33
Orientation of spin-labeled myosin heads in glycerinated muscle fibers. Biophys J (1980) 4.12
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Orientation of spin labels attached to cross-bridges in contracting muscle fibres. Nature (1982) 3.80
Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell (1985) 3.78
The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50
A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science (1985) 3.42
Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. Infect Immun (1986) 3.39
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med (1992) 3.30
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Submillisecond rotational dynamics of spin-labeled myosin heads in myofibrils. Biophys J (1980) 2.88
Erythema chronicum migrans--a tickborne spirochetosis. Acta Trop (1983) 2.85
Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect Immun (1989) 2.76
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins. Infect Immun (1992) 2.67
Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A (1998) 2.56
Cloning of 18S and 25S rDNAs from the pathogenic fungus Cryptococcus neoformans. J Bacteriol (1989) 2.55
The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg (1985) 2.50
Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect Immun (1989) 2.45
Linear- and circular-plasmid copy numbers in Borrelia burgdorferi. J Bacteriol (1992) 2.45
High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect Immun (1995) 2.39
Polymorphisms of major surface proteins of Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 2.33
Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domain. J Exp Med (1985) 2.32
In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis (1993) 2.31
Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif (1990) 2.23
Linear plasmids of Borrelia burgdorferi have a telomeric structure and sequence similar to those of a eukaryotic virus. J Bacteriol (1991) 2.15
Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1987) 2.15
Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis (1998) 2.15
Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides. J Exp Med (1985) 2.12
Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi. J Infect Dis (1989) 2.12
An outbreak of giardiasis in a group of campers. Am J Trop Med Hyg (1976) 2.04
The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids. Genetics (1992) 2.00
Rotational dynamics of spin-labeled F-actin in the sub-millisecond time range. J Mol Biol (1979) 1.99
Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun (1993) 1.98
A flagella-less mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization. J Clin Invest (1991) 1.95
A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun (1994) 1.89
Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A (1990) 1.87
Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome. Infect Immun (1981) 1.84
Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA (1996) 1.82
Motion of subfragment-1 in myosin and its supramolecular complexes: saturation transfer electron paramagnetic resonance. Proc Natl Acad Sci U S A (1975) 1.81
Methodology for increased precision in saturation transfer electron paramagnetic resonance studies of rotational dynamics. Biophys J (1986) 1.80
An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo. Infect Immun (1993) 1.79
Nucleotide sequence and analysis of the gene in Borrelia burgdorferi encoding the immunogenic P39 antigen. FEMS Microbiol Lett (1994) 1.77
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol (1992) 1.75
A large and distinct rotation of the myosin light chain domain occurs upon muscle contraction. Proc Natl Acad Sci U S A (1998) 1.75
Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Infect Immun (1999) 1.74
Immunochemical analysis of Lyme disease spirochetes. Yale J Biol Med (1985) 1.74
Expert advice and patient expectations: laboratory testing and antibiotics for Lyme disease. JAMA (1998) 1.73
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med (1994) 1.73
Properties of penicillin-binding proteins in Neisseria gonorrhoeae. Antimicrob Agents Chemother (1981) 1.72
Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol (1985) 1.71
Effects of AMPPNP on the orientation and rotational dynamics of spin-labeled muscle cross-bridges. Biophys J (1988) 1.70
Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry (1997) 1.63
New EPR methods for the study of very slow motion: application to spin-labeled hemoglobin. Ann N Y Acad Sci (1973) 1.60
Spectroscopic probes of muscle cross-bridge rotation. Annu Rev Physiol (1987) 1.60
Antigenic variation and strain heterogeneity in Borrelia spp. Res Microbiol (1993) 1.60
Photolysis of a photolabile precursor of ATP (caged ATP) induces microsecond rotational motions of myosin heads bound to actin. Proc Natl Acad Sci U S A (1989) 1.58
Rotational dynamics of actin-bound myosin heads in active myofibrils. Biochemistry (1993) 1.58
Electron paramagnetic resonance reveals age-related myosin structural changes in rat skeletal muscle fibers. Am J Physiol Cell Physiol (2001) 1.56
Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic. Mol Microbiol (1992) 1.55
Cloning and sequence analysis of linear plasmid telomeres of the bacterium Borrelia burgdorferi. Mol Microbiol (1990) 1.54
Transients in orientation of a fluorescent cross-bridge probe following photolysis of caged nucleotides in skeletal muscle fibres. J Mol Biol (1992) 1.52
The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol Microbiol (1990) 1.52
Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun (1997) 1.51
Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study. Biochemistry (1999) 1.50
Structural analysis of the variable major proteins of Borrelia hermsii. J Exp Med (1983) 1.50
A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban. Biophys J (1999) 1.50
Occupational lead poisoning in the United States: clinical and biochemical findings related to blood lead levels. Br J Ind Med (1979) 1.50
Microsecond rotational motions of eosin-labeled myosin measured by time-resolved anisotropy of absorption and phosphorescence. J Mol Biol (1984) 1.48
Enhanced EPR sensitivity from a ferroelectric cavity insert. J Magn Reson (2001) 1.45
Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genes. Cell (1994) 1.44
Myosin heads have a broad orientational distribution during isometric muscle contraction: time-resolved EPR studies using caged ATP. Proc Natl Acad Sci U S A (1990) 1.44
A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Infect Immun (1993) 1.43
Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation. Proc Natl Acad Sci U S A (2005) 1.43
Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae. Infect Immun (1997) 1.42
Action of penicillin on Borrelia hermsii. Antimicrob Agents Chemother (1982) 1.42